We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Finger Prick Test Could Transform Heart Attack Prevention

By LabMedica International staff writers
Posted on 14 Feb 2025

Currently, blood-thinning medications are prescribed only to patients who have already experienced a heart attack or stroke, as these drugs can lead to serious bleeding in some individuals. More...

Due to the lack of a reliable method to predict who may benefit or be harmed by these medications, doctors have been unable to prescribe them preventively to high-risk patients. Now, a new study suggests that a simple scoring system could transform how doctors prevent heart attacks and strokes by identifying patients who are most likely to benefit from preventive treatment.

The innovative test, known as the TRIPLE Score, was developed by researchers at the University of Reading (Berkshire, UK). It measures specific proteins on blood platelets, along with the patient's age, to help doctors make better-informed decisions about prescribing blood-thinning medications like aspirin and clopidogrel. Although the test is not yet widely available, the goal is to eventually make it suitable for point-of-care use. It will be incorporated into patient studies to verify its potential to enhance care.

In their study, published in Circulation Research, the team demonstrated that the TRIPLE Score effectively identified patients whose blood was more prone to forming clots in laboratory tests. The findings also correlated with established risk scores used by doctors to estimate a patient’s likelihood of having a heart attack within the next 10 years. The test requires just a small blood sample and could be developed into a simple tool that healthcare providers, not just specialists, could use in practice.

“Our new test will help doctors make sure that patients receive the best treatment and keep their quality of life,” said Dr. Alexander Bye, lead author of the research at the University of Reading. “Next, we aim to make the test even easier to use by developing a finger prick test, so that it as simple as measuring blood glucose."


Gold Member
Troponin T QC
Troponin T Quality Control
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
New
Respiratory Infections Test
STANDARD Q Adeno Respi Ag Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: Results of AI-based 3D virtual H&E staining and quantitative analysis of pathological tissue (Photo courtesy of Nature Communications, DOI:10.1038/s41467-025-59820-0)

Virtual Staining Technology Paves Way for Non-Invasive Pathological Diagnosis

For more than 200 years, traditional pathology has depended on the technique of examining cancer tissues under a microscope, a method that provides only limited, specific cross-sections of the 3D structure... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.